Dudediligence.

Liquidia Corporation

LQDANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$4.4MSep ’24$2.9MDec ’24$3.1MMar ’25$8.8MJun ’25$54.3MSep ’25$92.0MDec ’25$132.9MMar ’26$171.7MJun ’26
Net income, by quarter
−$31.0MSep ’24−$38.5MDec ’24−$38.4MMar ’25−$41.6MJun ’25−$3.5MSep ’25$14.6MDec ’25$52.9MMar ’26$74.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$12.9M$15.9M$17.5M$14.0M$158.3M
Gross profit$9.8M$13.1M$14.6M$8.1Mnone on file
Operating income−$33.8M−$38.8M−$73.4M−$121.3M−$51.4M
Net income−$34.6M−$41.0M−$78.5M−$128.3M−$68.9M
Operating cash flow−$34.0M−$28.6M−$41.6M−$93.4M−$35.7M
Free cash flow−$34.1M−$29.2M−$42.9M−$98.4M−$40.0M
Cash$57.5M$93.3M$83.7M$176.5M$190.7M
Debt$10.4M$19.9Mnone on filenone on filenone on file
Shares outstanding52.3M64.5M68.6M84.7M87.2M